| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |